Description
Urapidilisanα1-adrenergicreceptorantagoNISTand5-HT1Areceptoragonist.Urapidilexhibitsantihypertensiveactivity,inducingvasodilationanddecreasingbloodpressurewithoutcausingreflextachycardia.
Urapidilisanα1-adrenergicreceptorantagoNISTand5-HT1Areceptoragonist.Urapidilexhibitsantihypertensiveactivity,inducingvasodilationanddecreasingbloodpressurewithoutcausingreflextachycardia.
CasNo. | 34661-75-1 |
---|---|
Purity | ≥98% |
Formula | C20H29N5O3 |
FormulaWt. | 387.48 |
ChemicalName | 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]-amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione |
IUPACName | 6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione |
Synonym | Ebrantil |
MeltingPoint | 156-158°C |
Solubility | SolubleinH2O. |
Appearance | WhiteCrystalPowder |
StoreTemp | Ambient |
---|---|
ShipTemp | Ambient |
MSDS | U6801MSDSPDF |
---|---|
InfoSheet | U6801InfoSheetPDF |
SantiveriX,LedesmaM.Urapidilinanesthesiology:pharmacologyandindications.RevEspAnestesiolReanim.1998May;45(5):189-97.PMID:9646668.
vanZwietenPA,ChalmersJP.Differenttypesofcentrallyactingantihypertensivesandtheirtargetsinthecentralnervoussystem.CardiovascDrugsTher.1994Dec;8(6):787-99.PMID:7742257.